Horizon Discovery Ltd

Venture capital investors showed biopharmaceutical start-ups and growth-stage private companies some love with a trio of $100m-plus financings announced on 14 and 16 February, including a $236m series

UK-based Mogrify, Ltd. , which emerged from stealth mode in 2019, is using a big data-based platform technology to transform the development of ex vivo cell therapies and pioneer a new class of in

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Astellas Advances IO Ambitions With Two

With a big data-based platform technology that promises to circumvent some of the major challenges of developing and manufacturing cell therapies, Mogrify Ltd. emerged from stealth mode earlier this